Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
NCT04743362 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of this study is to find out whether using noninvasive methods to study the appearance of lesions can improve diagnostic accuracy before a biopsy is required and help guide treatment planning. The database created to store these images is called an Image Repository, and it will be used to support clinical practice, teaching and training, and future research.The High-resolution OCT (Apollo Medical Optics) device ApolloVue® S100 Image System (medical device Class II) can provide both cross-sectional and en-face images with cellular information.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Dermoscopic imaging
- DIAGNOSTIC_TEST 3-dimensional total body photography
- DIAGNOSTIC_TEST Confocal microscopy
- DIAGNOSTIC_TEST Optical Coherence Tomography imaging
- DIAGNOSTIC_TEST Ultrasound
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,010 participants |
| Start Date | 2021-02-02 |
| Est. Completion | 2031-08-02 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04743362
The ClinicalTrials.gov registry entry for NCT04743362 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 5,010 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 2,280 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Skin Lesion appearing as the primary indexed condition, and to 5 interventions — of which Dermoscopic imaging is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT04743362 reports 1 study location spanning 1 distinct geographic area — top geographies include New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT04743362 about?
NCT04743362 is a clinical study titled "A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions". The purpose of this study is to find out whether using noninvasive methods to study the appearance of lesions can improve diagnostic accuracy before a biopsy is required and help guide treatment planning. The database created to store these images is called an Image Repository, and it will be used t...
What is the current status of trial NCT04743362?
This trial is currently recruiting. The enrollment target is 5,010 participants. The study started on 2021-02-02. Estimated completion is 2031-08-02.
What conditions does trial NCT04743362 study?
This clinical trial studies the following conditions: Skin Lesion, Mucosal Lesion. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT04743362?
The interventions under investigation include: Dermoscopic imaging (DIAGNOSTIC_TEST), 3-dimensional total body photography (DIAGNOSTIC_TEST), Confocal microscopy (DIAGNOSTIC_TEST), Optical Coherence Tomography imaging (DIAGNOSTIC_TEST), Ultrasound (DIAGNOSTIC_TEST). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT04743362?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 2,280 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT04743362 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.